Table 2.
Patient’s study number | HFDS | Cancer treatment | CYP involved | CYP modification | Level | Supervised | Auto-implementation | Food questionnaire | HFDS type | HFDI category |
---|---|---|---|---|---|---|---|---|---|---|
3 | Green tea | Vinorelbine | CYP3A | Inhibition | 3 | Yes | No | No | Herb | Probable |
30 | Green tea | Paclitaxel | CYP3A | Inhibition | 3 | No | Yes | Yes | Food | Probable |
Licorice | Paclitaxel | CYP3A | Induction | 1 | No | Yes | Yes | Food | Probable | |
36 | Green tea | Letrozole | CYP3A | Inhibition | 3 | No | Yes | Yes | Food | Probable |
38 | Cranberry | Paclitaxel | CYP3A | Inhibition | 2 | No | Yes | Yes | Food | Probable |
Grapefruit | Paclitaxel | CYP3A | Inhibition | 1 | No | Yes | Yes | Food | Probable | |
40 | Coffee | Cyclophosphamide | CYP1A2 | Inhibition | 2 | No | Yes | Yes | Food | Probable |
44 | Green tea | Trastuzumab-emtansine | CYP3A | Inhibition | 3 | No | Yes | Yes | Food | Probable |
46 | Green tea | Paclitaxel | CYP3A | Inhibition | 3 | No | Yes | Yes | Food | Probable |
55 | Coffee | Cyclophosphamide | CYP1A2 | Inhibition | 2 | No | Yes | Yes | Food | Probable |
60 | Peppermint | Lenvatinib | CYP3A | Inhibition | 2 | No | Yes | No | Herb | Probable |
Green tea | Lenvatinib | CYP3A | Inhibition | 2 | No | Yes | Yes | Food | Probable | |
71 | Grapefruit | Dexamethasone | CYP3A | Inhibition | 1 | Yes | Yes | Yes | Food | Probable |
73 | Cranberry | Lapatinib | CYP3A | Inhibition | 2 | No | Yes | Yes | Food | Probable |
78 | Green tea | Ibrutinib | CYP3A | Inhibition | 3 | Yes | Yes | Yes | Food | Probable |
79 | Green tea | Vinblastine | CYP3A | Inhibition | 3 | Yes | Yes | Yes | Food | Probable |
Pomelo | Vinblastine | CYP3A | Inhibition | 3 | Yes | Yes | Yes | Food | Probable | |
85 | Coffee | Cyclophosphamide | CYP1A2 | Inhibition | 2 | Yes | Yes | Yes | Food | Probable |
87 | Green tea | Vinblastine | CYP3A | Inhibition | 3 | No | Yes | Yes | Food | Probable |
Pomelo | Vinblastine | CYP3A | Inhibition | 3 | No | Yes | Yes | Food | Probable | |
Grapefruit | Vinblastine | CYP3A | Inhibition | 1 | No | Yes | Yes | Food | Probable | |
89 | Coffee | Cyclophosphamide | CYP1A2 | Inhibition | 2 | No | Yes | Yes | Food | Probable |
The scale for the HFDS level of evidence of interaction with cytochromes is available in Supplementary Table S1, available at https://doi.org/10.1016/j.esmoop.2022.100650, and has been reported in a previous study.13 Version 2 of the application allowed both auto-implementation and the acquisition of CYP-interacting food through a specific food questionnaire. In version 2 of the application, food–drug interactions could be detected either through the general questionnaire or the specific food questionnaire.
CYP, cytochrome P-450; HFDI, herb and food–drug interaction; HFDS, herb, food and dietary supplements.